Frederic Pla - Sep 7, 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Chief Operating Officer
Signature: /s/ Frederic Pla, by Brian McKelligon, as Attorney-in-Fact
Stock symbol: AKYA
Transactions as of: Sep 7, 2023
Transactions value $: $92,014
Form type: 4
Date filed: 9/11/2023, 04:00 PM
Previous filing: Mar 27, 2023
Next filing: Nov 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKYA	Common Stock	Purchase	$59.8K	+13K		$4.60	13K	Sep 7, 2023	By The Pla Family Trust dtd 8/7/14	F1
transaction	AKYA	Common Stock	Purchase	$32.2K	+7K	+53.85%	$4.60	20K	Sep 7, 2023	By The Pla Family Trust dtd 8/7/14
holding	AKYA	Common Stock						40.6K	Sep 7, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $4.595 to $4.61 for a weighted average sale price of $4.6011. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $4.595 to $4.61 for a weighted average sale price of $4.6011. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.